Back to results
US 2022/0087998 A1Published application
Pharmaceutical drug therapy for autism
AssigneeNew Perception Research Pharmaceuticals L.L.C.
InventorLeland Cobb
Life of this patent
Estimating the term…
Abstract
A pharmaceutical drug therapy for autism is disclosed, including a sufficient amount of nicotine and a sufficient amount of amphetamine.
Claims20
A pharmaceutical drug therapy for autism, comprising:
- a sufficient amount of nicotine;
- and
- a sufficient amount of amphetamine,
- wherein the sufficient amount of nicotine and the sufficient amount of amphetamine are administered to a human.
1 more element
A pharmaceutical drug therapy for autism, comprising:
- between 2-20 mg of nicotine;
- and
- between 2-25 mg of amphetamine,
- wherein the nicotine and the amphetamine are administered to a human.
1 more element
A pharmaceutical drug therapy for autism, comprising:
- between 2-20 mg per day of ionized nicotine;
- and
- between 2-25 mg per day of 1-amphetamine provided in an extended-release form;
- wherein the nicotine and the amphetamine are administered to a human.
1 more element
Dependencies are inferred from the claim text.